Lauria Simone, Casati Silvana, Ciuffreda Pierangela
Dipartimento di Scienze Biomediche e Cliniche "Luigi Sacco", Università degli Studi di Milano, via G. B. Grassi 74, 20157, Milan, Italy.
Anal Bioanal Chem. 2015 Oct;407(26):8163-7. doi: 10.1007/s00216-015-8991-9. Epub 2015 Sep 2.
Human monoacylglycerol lipase (MAGL), a soluble serine hydrolase that belongs to the α/β hydrolase fold superfamily, regulates 2-arachidonoyl glycerol level in the endocannabinoid system, which is implicated in a number of severe diseases, and therefore, inhibition of MAGL activity is crucial in the treatment of these diseases. We have synthesized a red fluorogenic substrate, 7-hydroxyresorufinyl-arachidonate (7-HRA), for a new MAGL assay. This assay is simple, sensitive, and reliable and useful for identifying compounds that modulate MAGL activity. In addition, the assay emits red fluorescence, which can significantly reduce interference due to compound fluorescence and dust or lint, all of which fluoresce in the blue wavelength. MAGL catalyzes the hydrolysis of 7-HRA to generate arachidonic acid and a highly red fluorescent resorufin, excitation at 571 nm and emission at 588 nm, with a Km of 0.87 μM and Vmax of 26 nmol min(-1) mg protein(-1). The known MAGL inhibitors URB602, methyl arachidonyl fluorophosphonate, and JZL184 were used to validate the test assay. The assay was highly reproducible with an overall average Z' value of 0.80. This new red fluorogenic substrate and the resulting enzyme assay could be used in high-throughput screening to identify and develop new potential MAGL inhibitors.
人单酰甘油脂肪酶(MAGL)是一种可溶性丝氨酸水解酶,属于α/β水解酶折叠超家族,它调节内源性大麻素系统中2-花生四烯酸甘油酯的水平,而该系统与多种严重疾病有关,因此,抑制MAGL活性对这些疾病的治疗至关重要。我们合成了一种红色荧光底物7-羟基试卤灵花生四烯酸酯(7-HRA),用于一种新的MAGL检测方法。该检测方法简单、灵敏、可靠,可用于鉴定调节MAGL活性的化合物。此外,该检测方法发出红色荧光,可显著减少由于化合物荧光以及灰尘或绒毛产生的干扰,所有这些在蓝色波长下都会发出荧光。MAGL催化7-HRA水解生成花生四烯酸和一种高红色荧光的试卤灵,激发波长为571nm,发射波长为588nm,Km为0.87μM,Vmax为26nmol min(-1) mg蛋白(-1)。使用已知的MAGL抑制剂URB602、甲基花生四烯酰基氟磷酸酯和JZL184来验证该检测方法。该检测方法具有高度可重复性,总体平均Z'值为0.80。这种新的红色荧光底物以及由此产生的酶检测方法可用于高通量筛选,以鉴定和开发新的潜在MAGL抑制剂。